PetIQ, Inc. (NASDAQ:PETQ) had its price objective hoisted by Jefferies Group LLC from $25.00 to $26.00 in a research report sent to investors on Tuesday. The firm currently has a hold rating on the stock. Jefferies Group also issued estimates for PetIQ’s FY2017 earnings at $0.76 EPS, FY2018 earnings at $0.89 EPS and FY2019 earnings at $1.18 EPS.

Several other analysts have also issued reports on PETQ. Oppenheimer Holdings, Inc. began coverage on PetIQ in a report on Tuesday, August 15th. They set an outperform rating and a $28.00 target price on the stock. SunTrust Banks, Inc. began coverage on PetIQ in a report on Tuesday, August 15th. They set a buy rating and a $28.00 target price on the stock. William Blair began coverage on PetIQ in a report on Tuesday, August 15th. They set an outperform rating on the stock. Raymond James Financial, Inc. began coverage on PetIQ in a report on Tuesday, August 15th. They set an outperform rating and a $26.00 target price on the stock. Finally, CIBC began coverage on PetIQ in a report on Tuesday, August 15th. They set an outperform rating and a $28.00 target price on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of Buy and an average price target of $27.20.

PetIQ (PETQ) traded down $2.79 on Tuesday, reaching $19.70. The company had a trading volume of 1,451,313 shares, compared to its average volume of 255,238. PetIQ has a fifty-two week low of $18.92 and a fifty-two week high of $28.23. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.96 and a current ratio of 4.24.

ILLEGAL ACTIVITY WARNING: This article was reported by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.watchlistnews.com/jefferies-group-llc-raises-petiq-inc-petq-price-target-to-26-00/1694066.html.

A number of large investors have recently added to or reduced their stakes in PETQ. Eos Management L.P. bought a new stake in PetIQ in the third quarter valued at approximately $143,836,000. Wasatch Advisors Inc. bought a new stake in PetIQ in the third quarter valued at approximately $7,229,000. Cortina Asset Management LLC bought a new stake in PetIQ in the third quarter valued at approximately $5,956,000. Chartwell Investment Partners LLC bought a new stake in PetIQ in the third quarter valued at approximately $3,228,000. Finally, EAM Investors LLC bought a new stake in PetIQ in the third quarter valued at approximately $2,615,000. Hedge funds and other institutional investors own 1.46% of the company’s stock.

PetIQ Company Profile

PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.

Analyst Recommendations for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.